- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.92 Å
- Oligo State
- hetero-1-1-1-1-mer
- Ligands
- 1 x QL8: 2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1~{H}-isoquinolin-2-yl]-5-[3-[4-[3-[2-[2-[2-[2-[2-[3-[[(2~{S})-3,3-dimethyl-1-[(2~{S},4~{R})-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methylcarbamoyl]-4-oxidanyl-pyrrolidin-1-yl]-1-oxidanylidene-butan-2-yl]amino]-3-oxidanylidene-propoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]prop-1-ynyl]phenoxy]propyl]-1,3-thiazole-4-carboxylic acid(Non-covalent)
- 17 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 6 residues within 4Å:- Chain A: Q.15, R.50, N.83, G.86, Q.87, P.88
Ligand excluded by PLIPEDO.3: 5 residues within 4Å:- Chain A: G.35, E.36, P.37, Q.137, L.140
Ligand excluded by PLIPEDO.4: 4 residues within 4Å:- Chain A: R.109, S.110, V.112, K.113
Ligand excluded by PLIPEDO.5: 3 residues within 4Å:- Chain A: R.118, L.120, I.122
Ligand excluded by PLIPEDO.16: 2 residues within 4Å:- Chain B: C.89, I.90
Ligand excluded by PLIPEDO.17: 5 residues within 4Å:- Chain B: F.25, R.29, P.38, P.39, D.40
Ligand excluded by PLIPEDO.18: 4 residues within 4Å:- Chain B: E.20, S.21, T.56, G.58
Ligand excluded by PLIPEDO.19: 6 residues within 4Å:- Chain B: R.68, P.69, Q.70
- Chain C: Y.67, P.75
- Ligands: EDO.25
Ligand excluded by PLIPEDO.20: 3 residues within 4Å:- Chain B: Q.49, L.50, D.52
Ligand excluded by PLIPEDO.23: 4 residues within 4Å:- Chain A: V.123, L.126
- Chain C: M.89, N.92
Ligand excluded by PLIPEDO.24: 3 residues within 4Å:- Chain C: K.56, P.78, A.80
Ligand excluded by PLIPEDO.25: 3 residues within 4Å:- Chain C: E.73, P.75
- Ligands: EDO.19
Ligand excluded by PLIPEDO.26: 4 residues within 4Å:- Chain B: D.2, F.4, S.64
- Chain C: R.66
Ligand excluded by PLIPEDO.31: 5 residues within 4Å:- Chain D: P.86, M.87, A.88, A.89
- Ligands: EDO.34
Ligand excluded by PLIPEDO.32: 4 residues within 4Å:- Chain D: Q.115, S.126, Q.129, V.130
Ligand excluded by PLIPEDO.33: 4 residues within 4Å:- Chain D: Y.124, A.172, W.173, T.176
Ligand excluded by PLIPEDO.34: 3 residues within 4Å:- Chain D: P.86, A.89
- Ligands: EDO.31
Ligand excluded by PLIP- 9 x GOL: GLYCEROL(Non-functional Binders)
GOL.6: 4 residues within 4Å:- Chain A: R.24, R.103, Q.106
- Ligands: GOL.10
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:R.103, A:R.103, A:Q.106
- Water bridges: A:R.24, A:R.24
GOL.7: 5 residues within 4Å:- Chain A: N.73, L.77, F.78, V.79, I.89
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.73, A:V.79
GOL.8: 6 residues within 4Å:- Chain A: G.69, L.71, P.96, D.139, R.142
- Ligands: IOD.14
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:D.139, A:R.142
- Water bridges: A:R.62, A:G.69
GOL.9: 4 residues within 4Å:- Chain A: I.17, R.50, P.88, F.90
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.50, A:R.50
GOL.10: 7 residues within 4Å:- Chain A: P.23, R.24, V.25, D.63, G.65, T.66
- Ligands: GOL.6
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:V.25, A:G.65, A:T.66
- Water bridges: A:T.66
GOL.27: 7 residues within 4Å:- Chain A: L.71, P.96, V.97
- Chain C: Y.67, T.68, N.69, S.70
5 PLIP interactions:3 interactions with chain C, 2 interactions with chain A- Hydrogen bonds: C:N.69, C:S.70, C:S.70, A:V.97, A:V.97
GOL.35: 5 residues within 4Å:- Chain D: N.132, F.135, G.138, Y.177, H.181
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:G.138, D:Y.177, D:H.181
GOL.36: 4 residues within 4Å:- Chain D: S.18, Y.19, S.22, R.95
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:S.18, D:S.22, D:R.95, D:R.95
GOL.37: 5 residues within 4Å:- Chain D: N.140, W.141, G.142, L.198, Y.199
7 PLIP interactions:7 interactions with chain D- Hydrogen bonds: D:W.141, D:G.142
- Water bridges: D:N.140, D:N.140, D:W.141, D:Y.199, D:Y.199
- 12 x IOD: IODIDE ION(Non-functional Binders)
IOD.11: 2 residues within 4Å:- Chain A: H.67, V.136
Ligand excluded by PLIPIOD.12: 1 residues within 4Å:- Chain D: R.136
Ligand excluded by PLIPIOD.13: 1 residues within 4Å:- Chain A: R.55
Ligand excluded by PLIPIOD.14: 2 residues within 4Å:- Chain A: T.99
- Ligands: GOL.8
Ligand excluded by PLIPIOD.15: 3 residues within 4Å:- Chain A: I.51, H.52
- Ligands: QL8.1
Ligand excluded by PLIPIOD.21: 1 residues within 4Å:- Chain B: R.43
Ligand excluded by PLIPIOD.22: 1 residues within 4Å:- Chain B: H.10
Ligand excluded by PLIPIOD.28: 3 residues within 4Å:- Chain C: R.47, E.48, F.93
Ligand excluded by PLIPIOD.29: 1 residues within 4Å:- Chain B: P.96
Ligand excluded by PLIPIOD.30: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.38: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.39: 5 residues within 4Å:- Chain A: F.33
- Chain D: F.109, S.110, R.136
- Ligands: QL8.1
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chung, C.W. et al., Structural Insights into PROTAC-Mediated Degradation of Bcl-xL. Acs Chem.Biol. (2020)
- Release Date
- 2020-08-05
- Peptides
- von Hippel-Lindau disease tumor suppressor: A
Elongin-B: B
Elongin-C: C
Bcl-2-like protein 1: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AAAB
BBBC
CCCD
DDD
SMTL ID : 6zhc.1
PROTAC6 mediated complex of VHL:EloB:EloC and Bcl-xL
von Hippel-Lindau disease tumor suppressor
Elongin-B
Elongin-C
Bcl-2-like protein 1
Related Entries With Identical Sequence
1bxl.1 | 1lm8.1 | 1lqb.1 | 1lqb.2 | 1lxl.1 | 1maz.1 | 2fnj.1 | 2jz3.1 | 3zkj.1 | 3zkj.2 | 4n9f.1 | 4n9f.2 | 4n9f.3 | 4n9f.4 | 4n9f.5 | 4n9f.6 | 4n9f.7 | 4n9f.8 | 4n9f.9 | 4n9f.10 | 4n9f.11 | 4n9f.12 | 4wqo.1 | 6bvb.1 | 6c5x.1 | 6c5x.2 | 7khh.1 | 7m6t.1 | 7pi4.1 | 7s4e.1 more...less...7s4e.2 | 7upn.1 | 8ei3.1 | 8ei3.2 | 8ewv.1 | 8ewv.2 | 8ewv.3 | 8ewv.4 | 8ewv.5 | 8ewv.6 | 8fvi.1 | 8fvj.1 | 8fy1.1 | 8fy2.1 | 8g1q.1 | 8jaq.1 | 8jar.1 | 8jas.1 | 8jau.1 | 8jav.1 | 8rx0.1 | 8sh2.1 | 8szk.1 | 8vl9.1 | 8vlb.1 | 8wdk.1 | 8wqa.1 | 8wqb.1 | 8wqc.1 | 8wqe.1 | 8wqf.1 | 8wqg.1 | 8wqh.1 | 9bju.1 | 9bju.2 | 9bju.3 | 9bju.4 | 9bol.1 | 9bol.2